| 1 |
33213976 | The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial. | 2021 May |
1 |
| 2 |
33061877 | Vitamin D Deficiency has no Impact on PSA Reference Ranges in a General University Hospital - A Retrospective Analysis. | 2020 Sep |
3 |
| 3 |
30522147 | The Effect of Vitamin D Supplementation on Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials. | 2019 Jan |
5 |
| 4 |
31038028 | Effect of Vitamin D Supplementation in Prostate Cancer: A Systematic Review of Randomized Control Trials. | 2018 Feb |
1 |
| 5 |
26991691 | Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES. | 2016 Aug |
1 |
| 6 |
24190367 | The relationship between solar UV exposure, serum vitamin D levels and serum prostate-specific antigen levels, in men from New South Wales, Australia: the CHAMP study. | 2014 Oct |
1 |
| 7 |
24974387 | Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial. | 2014 Sep |
1 |
| 8 |
22955340 | Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring. | 2013 Mar |
2 |
| 9 |
19426197 | The promiscuous receptor. | 2009 Nov |
4 |
| 10 |
18649741 | 25-Hydroxyvitamin D-1 alpha-hydroxylase (CYP27B1) is a new class of tumor suppressor in the prostate. | 2008 Jul-Aug |
1 |
| 11 |
16988533 | Rise in prostate-specific antigen in men with untreated low-grade prostate cancer is slower during spring-summer. | 2006 Sep-Oct |
1 |
| 12 |
15749627 | Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. | 2005 |
2 |
| 13 |
9207192 | Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate-specific antigen by 1alpha,25-dihydroxyvitamin D3 in androgen-responsive LNCaP cells. | 1997 Jun 27 |
1 |
| 14 |
9815816 | Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion. | 1997 Aug |
1 |